High dose atorvastatin was superior to standard dose pravastatin in reducing death or major CV events in acute coronary syndrome

Outcomes: composite of major CV events: all cause death, myocardial infarction (MI), unstable angina requiring hospital readmission, revascularisation ([= or >, slanted]30 d after randomisation), and stroke. Outcomes at mean 24 months Atorvastatin Pravastatin RRR (CI) NNT (CI) Composite endpoint 22.4% 26.3% 16% (5 to 26) 19 (11 to 62) CHD death, non-fatal MI, or revascularisation 19.7% 22.3% 14% (2 to 25) 27 (15 to 230) Revascularisation 16.3% 18.8% 14% (0 to 26) 33 (17 to 647) UA requiring hospital admission 3.8% 5.1% 29% (5 to 47) 65 (35 to 436) *Composite endpoint = all cause death, myocardial infarction (MI), unstable angina (UA) requiring hospital readmission, revascularisation ([= or >, slanted]30 d after randomisation), and stroke; CHD = coronary heart disease.